Brief: Eurocine Vaccines Resolves On Scientific Advice With The Swedish Medical Products Agency Ahead Of Clinical Trial Application
Dec 21 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* EUROCINE VACCINES RESOLVES ON SCIENTIFIC ADVICE WITH THE
SWEDISH
MEDICAL PRODUCTS AGENCY AHEAD OF CLINICAL TRIAL APPLICATION
* PLANS TO INITIATE CLINICAL STUDY IN FIRST HALF-YEAR 2023
Source text for Eikon: ID:nWkr4vRlS
Further company coverage: EUCI.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate